Pratt Mark R MR

Show results for

Unknown (6)
Metabolomics (2)

Repository

MetaboLights (2)

Technology Type

Mass spectrometry (2)
NMR spectroscopy (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - hilic (2)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS – negative - hilic (1)
Liquid Chromatography MS – positive - reverse phase (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2023 (1)
2022 (1)

CHEBI ID

CHEBI:46195 (2)
CHEBI:10072 (1)
CHEBI:145223 (1)
CHEBI:15318 (1)
CHEBI:156419 (1)
CHEBI:156470 (1)
CHEBI:15724 (1)
CHEBI:16020 (1)
CHEBI:16040 (1)
CHEBI:16411 (1)
CHEBI:16449 (1)
CHEBI:16704 (1)
CHEBI:16737 (1)
CHEBI:16814 (1)
CHEBI:16914 (1)
CHEBI:16919 (1)
CHEBI:17012 (1)
CHEBI:17311 (1)
CHEBI:17368 (1)
CHEBI:17405 (1)
CHEBI:17509 (1)
CHEBI:17626 (1)
CHEBI:176458 (1)
CHEBI:17724 (1)
CHEBI:17768 (1)
CHEBI:17775 (1)
CHEBI:17802 (1)
CHEBI:17929 (1)
CHEBI:18101 (1)
CHEBI:18107 (1)

Metabolite Name

1,1-Dimethylbiguanide (Metformin) (1)
3-methylhistidine (1)
4-Trimethylammoniobutanoate (1)
7-Methylguanine (1)
Alanine (1)
Asymmetric Dimethylarginine (1)
Butyrylcarnitine (1)
Creatine (1)
Creatinine (1)
Cytosine (1)
Decadienoylcarnitine (C10:2) (1)
Glutarylcarnitine (1)
Hexanoylcarnitine (C6:0) (1)
Histidine (1)
Hypoxanthine (1)
Isovalerylcarnitine (1)
L-Acetylcarnitine (1)
N,N-Dimethylglycine (1)
N-Acetylputrescine (1)
N1-methyl-4-pyridone-3-carboxamide (1)
N2,N2-Dimethylguanosine (1)
N6,N6,N6-Trimethyllysine (1)
Octenoylcarnitine (C8:1) (1)
Pantothenate (1)
Phenylalanine (1)
Proline (1)
Proline Betaine (1)
Pseudouridine (1)
Thiamine (1)
Tiglylcarnitine (C5:1) (1)

Release Date

2024 (2)
2025 (1)
2021 (1)
2020 (1)
2019 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Metabolic phenotyping of urine from a dementia research cohort

To better understand the molecular mechanisms underpinning physiological variation in human populations, metabolic phenotyping approaches are increasingly being applied to studies involving hundreds and thousands of biofluid samples. Hyphenated ultra-performance liquid chromatography-mass spectromet...

2022-03-01 | MTBLS719 | MetaboLights

Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics

Untargeted metabolomics is an established approach in toxicology for characterising endogenous metabolic responses to xenobiotic exposure. Detecting the xenobiotic and its biotransformation products as part of the metabolomics analysis provides an opportunity to simultaneously gain deep insights int...

2023-07-03 | MTBLS2746 | MetaboLights

Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA.

Not available

S-EPMC7524039 | biostudies-literature

Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy.

Not available

S-EPMC6556837 | biostudies-literature

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

Not available

S-EPMC12303861 | biostudies-literature

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.

Not available